We are live on ! Find out more
ERNA icon

Eterna Therapeutics
ERNA

9 hedge funds and large institutions have $637K invested in Eterna Therapeutics in 2023 Q4 according to their latest regulatory filings, with funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 9 → 9 (0)

0% more ownership

Funds ownership: 0.02% → 0.02% (+0%)

13% less capital invested

Capital invested by funds: $728K → $637K (-$91.4K)

50% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 4

Holders
9
Holders Change
–
Holders Change %
0%
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
4
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SCA
Sippican Capital Advisors
Massachusetts
+$39.5K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$2.29K

Top Sellers

Rank Fund Capital Flow
1
Corient Private Wealth
Corient Private Wealth
Florida
-$1.72K
2
BWP
Baldwin Wealth Partners
Massachusetts
-$1.15K
3
BlackRock
BlackRock
New York
-$1.15K
4
NW
Naviter Wealth
Arkansas
-$573
5
UBS Group
UBS Group
Switzerland
-$229
Name Holding Trade Value Shares
Change 		Change in
Stake
CPWM
1
Cypress Point Wealth Management
Texas
$169K – – –
NW
2
Naviter Wealth
Arkansas
$141K -$573 -1 -0.5%
SCA
3
Sippican Capital Advisors
Massachusetts
$97K +$39.5K +69 +92%
Corient Private Wealth
4
Corient Private Wealth
Florida
$90.2K -$1.72K -3 -2%
Vanguard Group
5
Vanguard Group
Pennsylvania
$46.8K +$2.29K +4 +6%
Geode Capital Management
6
Geode Capital Management
Massachusetts
$40.3K – – –
BlackRock
7
BlackRock
New York
$28K -$1.15K -2 -5%
BWP
8
Baldwin Wealth Partners
Massachusetts
$15.3K -$1.15K -2 -8%
TRCT
9
Tower Research Capital (TRC)
New York
$7.91K – – –
Morgan Stanley
10
Morgan Stanley
New York
$180 – – –
MA
11
Montag & Associates
Georgia
$126 – – –
Wells Fargo
12
Wells Fargo
California
$50 – – –
Group One Trading
13
Group One Trading
Illinois
$34 – – –
Citigroup
14
Citigroup
New York
$27 – – –
PWA
15
Provenance Wealth Advisors
Florida
$27 – – –
JP Morgan Chase
16
JP Morgan Chase
New York
$25 – – –
APC
17
Aspire Private Capital
North Carolina
$17 – – –
Qube Research & Technologies (QRT)
18
Qube Research & Technologies (QRT)
United Kingdom
$7 – – –
Fidelity Investments
19
Fidelity Investments
Massachusetts
$2 – – –
UBS Group
20
UBS Group
Switzerland
– -$229 – –

ERNA Hedge Fund Activity: Q4 2023 in Review

9 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Eterna Therapeutics (ERNA) for Q4 2023, worth a combined $637K — down 13% from $728K a quarter earlier.

Fund positioning in ERNA was balanced in Q4 2023: 0 funds opened new positions, 0 closed out, 2 added to existing stakes and 4 trimmed.

The largest buyer was Sippican Capital Advisors, adding an estimated $39.5K. The largest seller was Corient Private Wealth, cutting an estimated $1.72K.

  • 9 institutional investors held Eterna Therapeutics (ERNA) as of Q4 2023, unchanged from Q3 2023.
  • Funds reported $637K of Eterna Therapeutics stock for Q4 2023, down 13% quarter-over-quarter.
  • 0 funds opened new Eterna Therapeutics positions in Q4 2023 and 0 closed out.
  • The largest Eterna Therapeutics buyer in Q4 2023 was Sippican Capital Advisors, an estimated $39.5K added.
  • The largest Eterna Therapeutics seller in Q4 2023 was Corient Private Wealth, an estimated $1.72K sold.

Based on aggregated 13F filings for Q4 2023.